Successful use of secukinumab in a 4-year-old patient with deficiency of interleukin-36 antagonist

Response to Interleukin (IL)-17 Inhibition in an Adolescent With Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA)

(2017) Kelly M. Cordoro et al.   JAMA Dermatology

IL36RNmutation causing generalized pustular psoriasis in a Palestinian patient

(2014) Yael Renert-Yuval et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

(2014) Richard G. Langley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bimodal immune activation in psoriasis

(2013) E. Christophers et al.   BRITISH JOURNAL OF DERMATOLOGY

First Clinical Description of an Infant With Interleukin-36-Receptor Antagonist Deficiency Successfully Treated With Anakinra

(2013) L. Rossi-Semerano et al.   PEDIATRICS

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

(2011) Slaheddine Marrakchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Generalized Pustular Psoriasis in Childhood

(2010) Sarah Toyomi De Oliveira et al.   PEDIATRIC DERMATOLOGY